4
Changes in Ownership
Vericel Corp Filed Acc 0001593968-20-002403
Chief Medical Officer sold 24,235 shares at an average $26.54 ($643,159)
- Chief Medical Officer acquired 43,264 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Option exercise | +5,000 | $10.95 | $54,750 | 9,331 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Sale | −5,000 | $26.27 | $131,374 | 4,331 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Option exercise | +18,264 | $10.95 | $199,991 | 22,595 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Sale | −7,526 | $26.61 | $200,244 | 15,069 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Option exercise | +20,000 | $10.95 | $219,000 | 35,069 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Sale | −11,709 | $26.61 | $311,541 | 23,360 | D |
| Derivatives | |||||||
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Option exercise · Stock Option (right to buy) | −5,000 | 130,000 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Option exercise · Stock Option (right to buy) | −20,000 | 110,000 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2020-12-21 | Option exercise · Stock Option (right to buy) | −18,264 | 91,736 | D | ||
| Open-market sales · 24,235 sh · avg $26.54 · $643,159 | |||||||
Loading xslF345X03/primary_01.xml…